Nexalin Technology (NXL) Net Cash Flow (2021 - 2026)
Nexalin Technology (NXL) posted quarterly Net Cash Flow of $553112.0 for Q1 2026, up 1063.37% year-over-year from $47544.0 in Q1 2025, and up 754.78% quarter-over-quarter from $64708.0 in Q4 2025.
Nexalin Technology (NXL) Net Cash Flow (2021 - 2026) Analysis & Trends
Nexalin Technology's Net Cash Flow history runs 6 years deep, the most recent figure standing at $553112.0 for Q1 2026.
- In Q1 2026, Net Cash Flow rose 1063.37% year-over-year to $553112.0; the TTM figure through Mar 2026 stood at -$4.1 million (up 8.56% YoY), while the FY2025 annual figure was $80298.0, up 1497.7% from the prior year.
- Net Cash Flow for Q1 2026 stood at $553112.0, up from $64708.0 in the prior quarter.
- The five-year high for Net Cash Flow was $7.6 million in Q3 2022, with the low at -$5.3 million in Q3 2024.
- The 5-year median for Net Cash Flow is $56761.0 (2023), against an average of -$107152.0.
- The sharpest annual moves came in 2024 and 2026: Net Cash Flow slumped 4174.46% in 2024, then surged 1063.37% in 2026.
- Nexalin Technology's Net Cash Flow stood at -$906457.0 in 2022, then surged by 124.14% to $218834.0 in 2023, then soared by 125.31% to $493064.0 in 2024, then tumbled by 86.88% to $64708.0 in 2025, then jumped by 754.78% to $553112.0 in 2026.
- Business Quant data shows NXL's Net Cash Flow at $553112.0 in Q1 2026, $64708.0 in Q4 2025, and $158755.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -1.70 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 527.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -892.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 458.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -8.30 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -183.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -926.40 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 45.10 Mn |
| 10 | Nexalin Technology | 7.04 Mn | 6.03 Mn | 8,897.00 | -202,937.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -202,937.00 |
| Jun 30, 2026 | -202,937.00 |
| Mar 31, 2026 | 553,112.00 |
| Mar 31, 2026 | 553,112.00 |
| Dec 31, 2025 | 64,708.00 |
| Dec 31, 2025 | 64,708.00 |
| Sep 30, 2025 | 158,755.00 |
| Sep 30, 2025 | 158,755.00 |
| Jun 30, 2025 | -4.84 Mn |
| Jun 30, 2025 | -4.84 Mn |
| Mar 31, 2025 | 47,544.00 |
| Mar 31, 2025 | 47,544.00 |
| Dec 31, 2024 | 493,064.00 |
| Dec 31, 2024 | 493,064.00 |
| Sep 30, 2024 | -5.28 Mn |
| Sep 30, 2024 | -5.28 Mn |
| Jun 30, 2024 | 302,541.00 |
| Jun 30, 2024 | 302,541.00 |
| Mar 31, 2024 | -33,975.00 |
| Mar 31, 2024 | -33,975.00 |